Member Info for Sangijuelas1

Don't be fooled.

Those broker targets were given at the peak of a biotech bull market.

When 4D was at $10 a share. They are over a year old so can't be considered a reliable indicator.

Provides cloud based Payments as a Service to banks and other regulated finance companies. So banks don't need to maintain infrastructure to process payments. Can just use Form3 tech. Insulates the banks from having to deal with payment issues and platform outages due to maintenance or faults.

Apparently a double digit percentage of Faster Payments in the UK are already running through their platform.

Statement from their CEO on website video.

"We will become the worlds most trusted provider of payments technology".

Value has not been publicly disclosed.

Goldman Sachs led the last funding round and other participants included Mastercard, Barclays, Lloyds, Nationwide and MV.

Seem to have a bright future.

Takes him to around 24%

Chesterman bought another $1m of Cazoo stock the other day

Yeah Dodl seems quite limited, basically Vanguard with a few UK shares

I see Freetrade had over £1bn AUM and only Hargreaves Landowne have more client daily trades.

I'll start the new thread now so it's there for later

Speaking of black box I wonder who the undisclosed deeptech investee is

Graphcore last raise was in Dec 20 at about $2. 7bn. They were burning a lot of cash at the time so maybe they are doing well as no raise since.

Their Supercomputer competitor Cerebras was valued at $4bn six months ago.

Graphcore are promising an AI human brain Supercomputer for $120m a pop by 2024!

Distribution channels look strong
https://www.graphcore.ai/partners

Freetrade - I see AJ Bell have launched Dodl which is basically a rip off of Freetrade.

Run from the same office as YouInvest. Wonder what their existing clients will make of continued charging for them and free trades for Dodl?

Ok You are probably right

UI Path and Prism are simply incomparable.

PATH have continually invested in their business whereas Prism thought they had done enough 5 years ago and effectively stopped investing.

Before the Prism offer came in I did a lot of research into them but every time it came back to the fact that PATH were streets ahead.

They have just poached the head of sales at Google Cloud and appointed him as Co CEO. They aren't standing still.

German or French Revolut clients can use it as a current account, savings account, mortgage lender, trading app, international currency exchange and whatever other financial services products they want to add.

There are 72 companies in the portfolio but you always want to rest your case on Cazoo.

If Draper had taken part in the Revolut Series E then you would have more of a point.
They are claiming to be sufficiently profitable to not need another raise.

Sometimes with tech you require a lot of early stage investment to get say the Revolut Super App optimised. Then it's a case of deployment and scale up where costs come down.

I think they see themselves as having the same kind of reach as a bank that FB has

People assume they will be able to do a placing.

In a biotech bear market.

They want $45m. Half of the current market cap.

Maybe can source cash from elsewhere. Maybe not. Who knows?

The initial stage of significant value creation is happening off public markets with tech companies. By the time they get listed much of the value has already accumulated and public market investors are left holding the bag.

Sometimes it's a good bag like Facebook. Terrible IPO but those that stuck with it were rewarded over time.

The £2.5m investment that MV sold in UI Path was done for £44m. Clearly they own more and this will be down. I hold a decent stake in PATH buying between 18-20. I like the business without going into details. In 2 years time it will be worth $5 or $100.

Look at Thought Machine. They are being used by banks all over the world and Morgan St and Lloyds wouldn't be investing if they didn't think it's a winner.

If Revolut get the UK banking licence then that would easily justify the value as it would enable the US banking license as well. I don't think Draper took part in the Series E. Below is an interview from them today.

https://www.altfi.com/article/9272_revolut-ceo-nik-storonsky-weve-made-almost-every-mistake-possible-and-weve-learned-from-them

And if you don't understand my rationale it is to invest in growth opportunities with a 5-10 year time frame. And I think MV provides a sufficiently diversified portfolio to do that.

That's right Crl it's all a big conspiracy.

While it's true that all sorts of shenanigans go on, you don't have to be concerned if you know that a company has money.

You can sit back and relax whatever the SP if the money is there. Less so if it's not

Well he is not going to provide me with inside info so I wouldn't waste my time with that.

The repetitive comment about the $7.5m is a matter of life or death for 4D.

If it had to be deducted from the end of year balance?

So why has it not started? Was scheduled for Q4 last year.

What's the hold up? Being done at MD Anderson who have a big roster of potential patients.

They only need 30

I know you guys believe in a Magic Money Tree but I don't.

£15m cash at end of the 2021.

Burn £2m a month but will probably be making cutbacks. For example, possibly delaying start of Bavencio trial as was due to start Q4 last year.

So say they will have spent nearly £10m by the end of this month.

The big question for me is did the $7.5m they had to return to Oxfords custodian account come off the end of the year cash balance?